喘息スペーサーの世界市場規模：タイプ別、流通チャネル別、地域範囲別および予測

喘息スペーサーの市場規模と予測

喘息スペーサー市場規模は、2024年に20億9,000万米ドルと評価され、2026年から2032年にかけてCAGR 3.21%で成長し、2032年には26億3,000万米ドルに達すると予測されます。

スペーサーは、喘息治療に使用される定量吸入器（MDI）の効率を向上させる装置です。スペーサーは通常、片方が吸入器に接続されたチューブ、もう片方がマウスピースまたはマスクで構成されています。吸入器から薬剤が放出されると、薬剤はスペーサーに入り、使用者はよりゆっくりと深く吸入することができ、肺への送達が改善され、口内炎などの副作用の可能性が低くなります。

さらにスペーサーは、幼児や重度の呼吸障害を持つ人など、吸入器を使用する際に調整が難しい人に特に有用です。また、口やのどに薬剤が沈着することなく、より多くの薬剤が気道に届くようにすることもできます。

喘息スペーサーの世界市場力学

喘息スペーサー市場を形成している主な市場力学は以下の通り：

主な市場促進要因

世界の喘息の有病率の増加：世界の喘息患者の増加は、喘息スペーサー市場の主要促進要因です。世界保健機関（WHO）によると、喘息は2019年に推定2億6,200万人に影響を与え、46万1,000人の命を奪いました。Global Asthma NetworkのGlobal Asthma Report 2022によると、喘息の有病率は過去10年間で3.6％増加しています。このような患者層の拡大により、スペーサーなどのより効果的な喘息コントロール技術が求められています。

大気汚染レベルの上昇と環境トリガー：大気汚染や環境変数の増加は喘息の症状を悪化させるため、スペーサーのような効果的な薬剤投与方法の使用が必要となります。世界銀行によると、10人中9人が汚染された空気を吸っています。The Lancet Planetary Healthに掲載された2022年の研究によると、大気汚染は毎年さらに180万人の子供の喘息発症の原因となっています。空気の質と喘息発症との関連は、スペーサーのような喘息管理器具の必要性が高まっていることを浮き彫りにしています。

適切な吸入方法に関する認識と教育の向上：患者教育や適切な吸入手技の重視の高まりが、薬物送達を改善し副作用を予防するためのスペーサーの使用を後押ししています。2019年にJournal of Asthmaに発表された系統的評価では、正しい吸入手技を使用している患者はわずか31％でした。スペーサーの使用は、薬の分配を大幅に増やすことができます。英国国立医療技術評価機構（NICE）は、加圧式定量吸入器（pMDI）を使用する12歳未満のすべての小児にスペーサーを使用するよう勧告しています。Asthma UKによると、スペーサーを正しく使用することで、肺へのドラッグデリバリーを10％～50％高めることができるといいます。

主な課題

高コスト：喘息用スペーサーの高価格は、市場にとって重要な課題です。多くの喘息患者、特に低所得者層はスペーサーの購入に苦労しており、そのため入手しやすく、利用しにくいという問題があります。このコスト障壁は個々の患者に影響を与えるだけでなく、ヘルスケアプロバイダーが患者が購入できない製品を提案することをためらうため、市場全体の成長も制限しています。その結果、効果的な喘息コントロール技術が十分に活用されないことが多いです。

代替機器との競合：喘息スペーサー市場は、ネブライザーやドライパウダー吸入器（DPI）などの代替機器とのさらなる競合に直面しています。消費者やヘルスケアプロバイダーの中には、これらの選択肢を好む者もいます。その結果、喘息スペーサーメーカーは、それぞれの利点を強調し、患者やヘルスケアシステムの変化するニーズを確実に満たすことで、製品の差別化に努めなければなりません。この競合環境は、スペーサーメーカーの市場ポジショニングと成長戦略を複雑にしています。

主要動向：

予防ヘルスケアへの注目の高まり：医療制度が喘息のような慢性疾患を悪化させる前に治療することに重点を置いているため、喘息用スペーサーは包括的な治療レジメンに不可欠なものとなっています。これらの器具は薬の投与を改善し、喘息発作の回数と重症度を下げます。このような予防的介入へのシフトは、患者の転帰を改善するだけでなく、より大きなヘルスケアコスト削減目標にも対応し、スペーサーの需要を増大させています。

新興市場における採用の増加：喘息治療と吸入療法の利点に対する認識が高まるにつれて、喘息有病率の高い地域では効果的な送達装置に対する需要が高まっています。ヘルスケアのインフラが改善し、喘息コントロール製品へのアクセスが増加するにつれて、メーカー各社はこれらの地域での普及に努めています。このような開発により、喘息スペーサー市場には大きな成長機会が生まれます。

目次

第1章 喘息スペーサーの世界市場導入

• 市場の導入
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 喘息スペーサーの世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 喘息スペーサーの世界市場、タイプ別

• 概要
• 容積式
• エアロチャンバー
• インスピラーゼ
• オプティチャンバー
• その他

第6章 喘息スペーサーの世界市場：流通チャネル別

• 概要
• 病院
• 小売薬局
• オンラインチャネル

第7章 喘息スペーサーの世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 世界の喘息スペーサー市場の競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第9章 企業プロファイル

• GlaxoSmithKline Plc.
• Trudell Medical International
• Conmed Corporation
• Medical Development International
• Royal Philips
• Clement Clarke International Ltd.
• Lupin Limited
• Vyaire Medical Inc.
• Pari GmbH
• AstraZeneca

第10章 主な発展

• 製品上市／開発
• 合併と買収
• 事業拡大
• パートナーシップと提携

第11章 付録

• 関連調査

Asthma Spacers Market Size And Forecast

Asthma Spacers Market size was valued at USD 2.09 Billion in 2024 and is projected to reach USD 2.63 Billion by 2032, growing at a CAGR of 3.21% from 2026 to 2032.

A spacer is a device that improves the efficiency of metered-dose inhalers (MDIs) used to deliver asthma treatments. It usually comprises a tube connected to the inhaler on one end and a mouthpiece or mask on the other. When the medication is released from the inhaler, it enters the spacer, allowing the user to inhale it more slowly and deeply, improving delivery to the lungs and lowering the chance of side effects such as mouth thrush.

Furthermore, spacers are especially useful for people who struggle to coordinate when using inhalers, such as young children or those who have severe breathing problems. They can also ensure that more medication reaches the airways instead of being deposited in the mouth and throat.

Global Asthma Spacers Market Dynamics

The key market dynamics that are shaping the Asthma Spacers Market include:

Key Market Drivers

Increasing Prevalence of Asthma Globally: The increasing number of asthma sufferers globally is a major driver of the Asthma Spacers Market, as these devices improve the efficacy of inhaled treatments. According to the World Health Organization (WHO), asthma affected an estimated 262 million people in 2019 and claimed 461,000 lives. According to the Global Asthma Network's Global Asthma Report 2022, the prevalence of asthma has increased by 3.6% over the last decade. This expanding patient group demands more effective asthma control techniques, such as spacers.

Rising Air Pollution Levels and Environmental Triggers: Increasing air pollution and environmental variables exacerbate asthma symptoms, necessitating the use of effective medicine delivery methods such as spacers. According to the World Bank, 9 out of every 10 individuals breathe polluted air. According to a 2022 study published in The Lancet Planetary Health, air pollution causes an additional 1.8 million asthma cases in children each year. The link between air quality and asthma incidence highlights the growing necessity of asthma management devices, such as spacers.

Increasing Awareness and Education about Proper Inhaler Technique: The increased emphasis on patient education and good inhaler technique is driving the use of spacers to improve medicine delivery and prevent adverse effects. A systematic evaluation published in the Journal of Asthma in 2019 discovered that only 31% of patients used the correct inhaler technique. The use of spacers can greatly increase medicine distribution. The UK's National Institute for Health and Care Excellence (NICE) advises spacers for all children under the age of 12 who use pressurized metered-dose inhalers (pMDIs). According to Asthma UK, correct usage of spacers can boost drug delivery to the lungs by 10% to 50%.

Key Challenges:

High Costs: The high cost of asthma spacers is a key challenge for the market. Many asthma sufferers, particularly in low-income areas, struggle to buy spacers, limiting their accessibility and utilization. This cost barrier not only affects individual patients but also limits overall market growth because healthcare providers are hesitant to propose products that patients can't buy. As a result, effective asthma control techniques are often underutilized.

Competition from Alternative Devices: The Asthma Spacers Market faces additional competition from alternative devices such as nebulizers and dry powder inhalers (DPIs). Some consumers and healthcare providers prefer these options because they are thought to be easier to use or more effective. As a result, asthma spacer producers must work hard to differentiate their products by emphasizing their distinct benefits and ensuring they satisfy the changing needs of patients and healthcare systems. This competitive environment complicates market positioning and growth strategies for spacer makers.

Key Trends:

Growing Focus on Preventive Healthcare: Asthma spacers are becoming essential to comprehensive treatment regimens as healthcare systems place a greater emphasis on treating chronic disorders like asthma before they escalate. These devices improve medicine administration, lowering the number and severity of asthma episodes. This shift toward preventative interventions not only improves patient outcomes but also corresponds with larger healthcare cost-cutting goals, increasing demand for spacers.

Increased Adoption in Emerging Markets: With increased awareness of asthma care and the benefits of inhalation therapy, there is a growing demand for effective delivery devices in areas with high asthma prevalence. As healthcare infrastructures improve and access to asthma control products increases, manufacturers are working on these areas to broaden their reach. This development creates considerable growth opportunities for the Asthma Spacers Market as more patients seek better ways to manage their condition.

Global Asthma Spacers Market Regional Analysis

Here is a more detailed regional analysis of the Asthma Spacers Market:

North America:

According to Verified Market Research, North America is estimated to dominate the Asthma Spacers Market over the forecast period. North America, particularly the United States, has a high asthma burden, which drives demand for asthma control devices such as spacers. According to the Centers for Disease Control and Prevention (CDC), over 25 million Americans had asthma in 2019, accounting for roughly one in every thirteen persons. This includes 5.1 million children. The CDC also says that asthma causes 1.6 million emergency department visits in the United States each year. These high numbers highlight North America's sizable market for asthma control products, including spacers.

Furthermore, the well-developed healthcare system and large healthcare expenditures in North America contribute to the increased adoption of medical devices such as asthma spacers. According to the Organisation for Economic Cooperation and Development (OECD), the United States spent 17.8% of its GDP on healthcare in 2021, the most of any OECD country. Canada's healthcare spending was likewise high, accounting for 11.3% of GDP. This high level of healthcare spending makes medical equipment like asthma spacers more accessible and widely used.

Asia Pacific:

The Asia Pacific region is estimated to exhibit the highest growth within the Asthma Spacers Market during the forecast period. The Asia Pacific region is rapidly urbanizing, resulting in increased air pollution, which is a major risk factor for asthma and promotes demand for asthma management devices such as spacers. According to the United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), Asia Pacific's urban population is expected to increase from 2.3 billion in 2019 to 3.5 billion in 2050. This urbanization is accompanied by deterioration in air quality. According to the World Health Organization (WHO), 98% of low- and middle-income cities in Asia Pacific with more than 100,000 people do not fulfill WHO air quality recommendations. The combination of urbanization and air pollution is anticipated to increase asthma prevalence, necessitating the use of appropriate management tools.

Furthermore, increased healthcare spending and improved healthcare infrastructure in the Asia Pacific are making medical equipment, such as asthma spacers, more accessible. According to the World Bank, health expenditure as a proportion of GDP in East Asia and the Pacific climbed from 6.4% in 2010 to 7.1% in 2019. In South Asia, it increased from 3.5% to 3.8% over the same period. This trend points to increased expenditure in healthcare, which is likely to improve access to asthma control devices such as spacers.

Global Asthma Spacers Market: Segmentation Analysis

The Asthma Spacers Market is segmented on the basis of Type and Distribution Channel.

Asthma Spacers Market, By Type

• Volumatic
• Aerochamber
• Inspirease
• Optichamber
• Others

Based on Type, the market is segmented into Volumatic, Aerochamber, Inspirease, Optichamber, and Others. The Aerochamber segment is estimated to dominate the Asthma Spacers Market due to its ability to improve medicine delivery from metered-dose inhalers (MDIs) to the lungs, hence enhancing asthma treatment outcomes. Aerochambers are built with characteristics that assist inhalation and reduce medicine waste, making them a popular choice among both healthcare providers and consumers. Their widespread acceptance and demonstrated efficacy continue to fuel their market dominance.

Asthma Spacers Market, By Distribution Channel

• Hospitals
• Retail Pharmacy
• Online Channel

Based on Distribution Channel, the market is segmented into Hospitals, Retail Pharmacy, and Online Channel. The retail pharmacy segment is estimated to dominate the Asthma Spacers Market during the forecast period due to consumers' increased preference for easy access to pharmaceuticals and tailored guidance from pharmacy professionals. Retail pharmacies offer a diverse choice of asthma spacer options, allowing patients to select from a variety of brands and varieties. Furthermore, the expansion of retail pharmacies during the pandemic has made asthma control equipment more accessible, consolidating their dominant position in the distribution channel landscape.

Key Players

• The "Asthma Spacers Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are GlaxoSmithKline Plc., Trudell Medical International, Conmed Corporation, Medical Development International, Royal Philips, Clement Clarke International Ltd., Lupin Limited, Vyaire Medical, Inc., Pari GmbH, AstraZeneca, Merck & Co.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Asthma Spacers Market Recent Developments
• In November 2023, the faculty of medicine at the National University of Science and Technology (NUST) in Zimbabwe announced the invention of a cheap spacer specifically for children. These spacers are meant to be supplied widely throughout Africa at a low cost, perhaps saving thousands of lives.
• In April 2021, Vyaire Medical Inc. (UK) announced the European launch of ArtiQ.PFT. ArtiQ.PFT is an artificial intelligence-powered automated tool for interpreting pulmonary function tests (PFTs). According to a multi-center study published in the European Respiratory Journal, the technology's algorithm identifies illness patterns in 82 percent of instances, but pulmonologists only identify 45 percent.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ASTHMA SPACERS MARKET

• 1.1 Introduction of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL ASTHMA SPACERS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL ASTHMA SPACERS MARKET, BY TYPE

• 5.1 Overview
• 5.2 Volumatic
• 5.3 Aerochamber
• 5.4 Inspirease
• 5.5 Optichamber
• 5.6 Others

6 GLOBAL ASTHMA SPACERS MARKET, BY DISTRIBUTION CHANNEL

• 6.1 Overview
• 6.2 Hospitals
• 6.3 Retail Pharmacy
• 6.4 Online Channel

7 GLOBAL ASTHMA SPACERS MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL ASTHMA SPACERS MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 GlaxoSmithKline Plc.
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Trudell Medical International
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Conmed Corporation
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Medical Development International
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Royal Philips
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Clement Clarke International Ltd.
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Lupin Limited
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Vyaire Medical Inc.
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Pari GmbH
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 AstraZeneca
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research